Archive 2018
1 - 8of about 12 News
1 - 8of about 12 News

Group to take comprehensive range of portfolio, efficiency and structural measures
Bayer to strengthen core life science businesses while significantly enhancing productivity and profitability

Third quarter of 2018
Bayer: Good performance in a challenging environment, Group outlook confirmed


Following completion of the divestment of Crop Science businesses to BASF
Bayer: Conditions for beginning Monsanto integration fulfilled

LEO Pharma to expand its lead in medical dermatology with acquisition of Bayer’s prescription dermatology unit



U. S. Department of Justice conditionally approves Bayer’s proposed acquisition of Monsanto
1 - 8of about 12 News
1 - 8of about 12 News